Showing results (31-40 of 229) with videos related to
Sort By:
Pageof 23
Alzheimer Disease and Associated Disorders|January 1, 1995
Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer diseaseF Licastro, L Parnetti, M C Morini, et al.Drugs & Aging|March 1, 1993
Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's typeL Parnetti, G Abate, L Bartorelli, et al.Molecular and Chemical Neuropathology|February 1, 1992
Platelet MAO-B activity and vitamin B12 in old age dementiasL Parnetti, P Mecocci, G P Reboldi, et al.Molecular and Chemical Neuropathology|February 1, 1992
CSF monoamine metabolites in old age dementiasL Parnetti, A Gaiti, G P Reboldi, et al.Aging (Milan, Italy)|June 1, 1994
Platelet MAO-B activity as a marker of behavioural characteristics in dementia disordersL Parnetti, G P Reboldi, C Santucci, et al.Brain, Behavior, and Immunity|September 1, 1992
Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementiasP Mecocci, L Parnetti, R Donato, et al.Thrombosis Research|July 15, 1997
Vascular dementia Italian sulodexide study (VA.D.I.S.S.). Clinical and biological resultsL Parnetti, D Mari, G Abate, et al.Neuroscience Letters|October 27, 1995
Increased cerebrospinal fluid pyruvate levels in Alzheimer's diseaseL Parnetti, A Gaiti, M C Polidori, et al.Atherosclerosis|April 1, 1990
Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical useG Crepaldi, R Fellin, A Calabrò, et al.Mechanisms of Ageing and Development|July 1, 1997
Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal agingL Parnetti, R Tarducci, O Presciutti, et al.Pageof 23